药品
药物发现
质量(理念)
鉴定(生物学)
选择(遗传算法)
生化工程
计算生物学
效力
药物开发
药理学
计算机科学
风险分析(工程)
化学
生物信息学
医学
机器学习
生物
生物化学
体外
工程类
植物
认识论
哲学
作者
John G. Cumming,Andrew M. Davis,Sorel Mureşan,Markus Haeberlein,Hongming Chen
摘要
The 'quality' of small-molecule drug candidates — encompassing aspects including their potency, selectivity and pharmacokinetic characteristics — is a key factor influencing the chances of success in clinical trials. Cumming and colleagues discuss the application of computational methods, particularly quantitative structure–activity relationships, in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their impact. The 'quality' of small-molecule drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) characteristics, is a key factor influencing the chances of success in clinical trials. Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compounds. Here, we discuss the application of computational methods, particularly quantitative structure–activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.
科研通智能强力驱动
Strongly Powered by AbleSci AI